Search Results

There are 2975533 results for: content related to: Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer

  1. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Article first published online : 24 APR 2012, DOI: 10.3322/caac.21141

  2. You have full text access to this OnlineOpen article
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Article first published online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  3. Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 109, Issue 7, April 2012, Pages: 968–985, Daniel J. Lee, Eugene K. Cha, Justin M. Dubin, Himisha Beltran, Thomas F. Chromecki, Harun Fajkovic, Douglas S. Scherr, Scott T. Tagawa and Shahrokh F. Shariat

    Article first published online : 28 OCT 2011, DOI: 10.1111/j.1464-410X.2011.10643.x

  4. New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Article first published online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  5. You have free access to this content
    Characterising the castration-resistant prostate cancer population: a systematic review

    International Journal of Clinical Practice

    Volume 65, Issue 11, November 2011, Pages: 1180–1192, M. Kirby, C. Hirst and E. D. Crawford

    Article first published online : 14 OCT 2011, DOI: 10.1111/j.1742-1241.2011.02799.x

  6. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

    The Prostate

    Volume 72, Issue 10, 1 July 2012, Pages: 1093–1103, Tong Sun, Ming Yang, Shaoyong Chen, Steven Balk, Mark Pomerantz, Chen-Lin Hsieh, Myles Brown, Gwo-Shu Mary Lee and Philip W. Kantoff

    Article first published online : 29 NOV 2011, DOI: 10.1002/pros.22456

  7. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer

    The Prostate

    Volume 72, Issue 11, 1 August 2012, Pages: 1171–1178, Bin Xu, Ning Wang, Xuhui Wang, Na Tong, Ning Shao, Jun Tao, Pengchao Li, Xiaobing Niu, Ninghan Feng, Lihua Zhang, Lixin Hua, Zengjun Wang and Ming Chen

    Article first published online : 7 DEC 2011, DOI: 10.1002/pros.22466

  8. Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 328–335, A. Oliver Sartor and John M. Fitzpatrick

    Article first published online : 19 JUN 2012, DOI: 10.1111/j.1464-410X.2011.10818.x

  9. Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1580–1588, Che-Kai Tsao, Matthew D. Galsky, Alexander C. Small, Tiffany Yee and William K. Oh

    Article first published online : 18 SEP 2012, DOI: 10.1111/j.1464-410X.2012.11445.x

  10. Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 14–22, Noel W. Clarke

    Article first published online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11430.x

  11. Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 658–667, Heather Payne, Amit Bahl, Malcolm Mason, Janis Troup and Johann De Bono

    Article first published online : 19 MAR 2012, DOI: 10.1111/j.1464-410X.2011.10886.x

  12. Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer

    The Prostate

    Volume 73, Issue 6, May 2013, Pages: 657–667, Anna Nordin, Wanzhong Wang, Karin Welén and Jan-Erik Damber

    Article first published online : 5 NOV 2012, DOI: 10.1002/pros.22607

  13. You have full text access to this OnlineOpen article
    Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone

    Cancer

    Volume 118, Issue 22, 15 November 2012, Pages: 5709–5718, Joel B. Nelson, Karim Fizazi, Kurt Miller, Celestia Higano, Judd W. Moul, Hideyuki Akaza, Thomas Morris, Stuart McIntosh, Kristine Pemberton and Martin Gleave

    Article first published online : 11 JUL 2012, DOI: 10.1002/cncr.27674

  14. Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1729–1735, Mari Nakabayashi, Lilian Werner, Kevin D. Courtney, Geoffrey Buckle, William K. Oh, Glen J. Bubley, Julia H. Hayes, Douglas Weckstein, Aymen Elfiky, Danny M. Sims, Philip W. Kantoff and Mary-Ellen Taplin

    Article first published online : 29 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11456.x

  15. Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer

    Histopathology

    Volume 60, Issue 4, March 2012, Pages: 645–652, Tarek A Bismar, Maisa Yoshimoto, Qiuli Duan, Shuhong Liu, Kanishka Sircar and Jeremy A Squire

    Article first published online : 19 JAN 2012, DOI: 10.1111/j.1365-2559.2011.04116.x

  16. You have free access to this content
    Diethylstilbestrol in castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E727–E735, Anna Wilkins, Mehdi Shahidi, Chris Parker, Ranga Gunapala, Karen Thomas, Robert Huddart, Alan Horwich and David Dearnaley

    Article first published online : 30 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11546.x

  17. Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer

    The Prostate

    Volume 72, Issue 14, 1 October 2012, Pages: 1491–1505, John T. Isaacs, Jason M. D'Antonio, Shuangling Chen, Lizamma Antony, Susan P. Dalrymple, Georges H. Ndikuyeze, Jun Luo and Samuel R. Denmeade

    Article first published online : 6 MAR 2012, DOI: 10.1002/pros.22504

  18. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

    The Prostate

    Volume 73, Issue 4, March 2013, Pages: 346–354, Han Christine Ngoc Nguyen, Wanling Xie, Ming Yang, Chen-Lin Hsieh, Sarah Drouin, Gwo-Shu Mary Lee and Philip W. Kantoff

    Article first published online : 10 AUG 2012, DOI: 10.1002/pros.22572

  19. Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 834–845, Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Kei Matsuoka, Gaku Arai, Satoko Matsueda, Tetsuro Sasada, Akira Yamada and Kyogo Itoh

    Article first published online : 19 SEP 2011, DOI: 10.1002/pros.21485

  20. Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer

    The Prostate

    Volume 72, Issue 7, 15 May 2012, Pages: 789–802, Paula Vainio, Maija Wolf, Henrik Edgren, Tao He, Pekka Kohonen, John-Patrick Mpindi, Frank Smit, Gerald Verhaegh, Jack Schalken, Merja Perälä, Kristiina Iljin and Olli Kallioniemi

    Article first published online : 14 SEP 2011, DOI: 10.1002/pros.21487